Predicting Clinical Outcomes Using Proteomics in Non-Small Cell Lung Cancer-The Past, Present, and Future

J Thorac Oncol. 2017 Apr;12(4):602-606. doi: 10.1016/j.jtho.2017.01.025.

Authors

Ross A Soo¹, Alex A Adjei²

Affiliations

¹ Cancer Science Institute of Singapore, National University of Singapore, Singapore; Department of Haematology-Oncology, National University Cancer Institute of Singapore, Singapore. Electronic address: [email protected].
² Department of Oncology, Mayo Clinic, Rochester, Minnesota.

PMID: 28343541
DOI: 10.1016/j.jtho.2017.01.025

No abstract available

Publication types

Editorial
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Biomarkers, Tumor
Carcinoma, Non-Small-Cell Lung*
Humans
Lung Neoplasms
Proteomics*

Substances

Biomarkers, Tumor